Table 2.
Estimate of deaths averted (in thousands) among children aged under 5 years by interventions in Eastern Mediterranean countries with mortality above 50/1000 live births
Intervention | No (%) of deaths prevented |
---|---|
Preventive | |
Family and community care: | |
Periconceptual folic acid | 4 (0.3) |
Promotion of breast feeding | 151 (10.8) |
Appropriate complementary feeding strategies including dietary diversification | 54 (3.9) |
Water, sanitation, and hygiene strategies | 31 (2.2) |
Outreach services: | |
Effective antenatal care | 17 (1.2) |
Tetanus toxoid administration | 36 (2.6) |
Intermittent preventive treatment of malaria in pregnancy | 2 (0.2) |
Insecticide treated materials for malaria | 24 (1.7) |
Vitamin A supplementation | 11 (0.8) |
Clinic based care: | |
Treatment of asymptomatic bacteriuria in pregnancy | 8 (0.6) |
Skilled maternal and immediate newborn care | 53 (3.8) |
Antenatal steroids in high risk cases (preterm births) | 23 (1.6) |
Extra care of low birthweight infants | 19 (1.4) |
Haemophillus influenzae B vaccine (as part of standard vaccination schedule) | 29 (2.1) |
Measles vaccine | 30 (2.1) |
Treatment | |
Family and community care: | |
Oral rehydration therapy | 65 (4.7) |
Appropriate antibiotics for pneumonia | 42 (3.0) |
Outreach services: | |
Zinc for diarrhoea | 4 (0.3) |
Appropriate antimalarials including artemisin combination | 4 (0.3) |
Clinic based care: | |
Antibiotics for preterm premature rupture of membranes | 5 (0.3) |
Emergency obstetric care | 19 (1.3) |
Emergency newborn care | 35 (2.5) |
Appropriate treatment of neonatal pneumonia | 31 (2.2) |
Antibiotics for dysentery | 6 (0.4) |
Vitamin A for measles | 1 (0.1) |
Antiretroviral treatment | 3 (0.2) |